Stock Ratings / Financials / NHI / forecast

BNL (56) HIW (70) IRT (62) CXW (56) ⌘ Pro Terminal →

National Health Investors Inc. (NHI) 12-Month Stock Forecast & Price Target Cone

$66.95 +1.93% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

National Health Investors Inc. (NHI) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $3.29B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-4.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NHI)Realized 20D OHLCV Swing Band: ±4.4%

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your NHI Position Size: $10,000

Shares at $66.95: 149.4 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $49.87

$7,449

$-2,551 (-25.5%)

12M Consensus BaseTarget $63.94

$9,550

$-450 (-4.5%)

12M Bull Case BreakoutTarget $95.95

$14,332

+$4,332 (+43.3%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (32 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 6

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$66	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$90	69%	B
JP MorganUS Large-Cap Research	SELL	$57	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NHI)

✓Walkthrough of NHI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NHI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.95%📐 HORIZONTAL RANGE

2026-10-30O $67.57H $67.80L $66.90C $66.95VOL 269.4K

RES: $87.55SUP: $61.18SMA50: $68.10SMA200: $76.38

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NHI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NHI Butterfly Map → + Track NHI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

16.9%/yr Implied 5Y Growth

vs. +47.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NHI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NHI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NHI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NHI)

Financials Rank #888 of 1096 ⚔️ BNL vs NHI Full Matrix →

1. Head-to-Head Financials Peer Comparison (NHI vs. BNL, HIW, IRT, CXW)

Industry: Real Estate Investment Trusts (172 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, National Health Investors Inc. (NHI) ranks #888 by composite RQD confidence (48/100, grade D) and #345 by equity capitalization ($3.29B). Within this direct 5-issuer industry benchmark cohort, NHI leads on earnings valuation at 23.1x trailing P/E, while HIW leads on capital efficiency and profitability with 18.3% ROIC and — gross margin. HIW currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with NHI at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NHI ACTIVE National Health Investors Inc.	D	48/100	23.1x	—	9.3%	+1.93%	$3.29B	Benchmark Subject
BNL Broadstone Net Lease Inc.	D+	56/100	34.6x	—	2.3%	+3.20%	$3.34B	/bnl-vs-nhi →
HIW Highwoods Properties Inc.	B-	70/100	—	—	18.3%	+4.42%	$3.36B	/hiw-vs-nhi →
IRT Independence Realty Trust Inc.	C	62/100	61.7x	—	1.6%	+2.42%	$3.49B	/irt-vs-nhi →
CXW CoreCivic Inc.	D+	56/100	—	—	—	+1.47%	$3.07B	/cxw-vs-nhi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000877860

In its most recent audited fiscal period (FY2025, filed 2025-12-31), National Health Investors Inc. (NHI) reported GAAP revenue of $80.1M (+47.1% vs. FY2024 revenue of $54.4M , and +64.0% cumulative change since FY2023) , GAAP net income of $142.2M, operating cash flow of $236.6M, and free cash flow of -$57.5M (-215.3% YoY). On the balance sheet, NHI closed FY2025 with $2.80B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$80.1M	$142.2M	$236.6M	-$57.5M	$2.80B	—
FY2024 (FY)	2024-12-31	$54.4M	$138.0M	$207.8M	$49.8M	$2.61B	—
FY2023 (FY)	2023-12-31	$48.8M	$135.7M	$184.4M	$184.4M	—	—

3. NHI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NHI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, National Health Investors Inc. (NYSE: NHI) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $66.95 (+1.93% 1D, market cap $3.29B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 8/20. Across 1096 tracked Financials issuers, NHI ranks #888 in composite RQD confidence.

How does NHI compare to BNL and HIW in the Financials sector?

Within the Financials sector (Real Estate Investment Trusts), NHI carries a Roarable D (48/100 RQD), trailing P/E of 23.1x, gross margin of —, and ROIC of 9.3%. By comparison, BNL (Broadstone Net Lease Inc.) holds a D+ grade (56/100 RQD, P/E 34.6x, ROIC 2.3%, cap $3.34B) and HIW (Highwoods Properties Inc.) posts a B- grade (70/100 RQD, P/E N/A, ROIC 18.3%, cap $3.36B). Among the 5-stock peer group, NHI leads on earnings multiple (23.1x) while HIW leads on capital efficiency (18.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NHI?

Per NHI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000877860), National Health Investors Inc. generated $80.1M in revenue (+47.1% YoY), $142.2M in net income, and -$57.5M in free cash flow against $2.80B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NHI trading relative to its 50-day, 200-day, and 52-week technical levels?

NHI last traded at $66.95 (+1.93% on volume of 182,947 shares), positioning the stock -1.69% below its 50-day simple moving average ($68.10) and -12.35% below its 200-day simple moving average ($76.38). Across its 52-week range of $63.51 to $91.38, NHI sits at the 12.3% percentile with a 14-day RSI of 51.6 (NEUTRAL RANGE) and an implied next-earnings move of ±4.4% ($64.00 to $69.90).

NHI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is NHI's 12-month stock price target?

National Health Investors Inc. (NHI) carries a 12-month consensus base price target of $63.94 (-4.5% from $66.95), with a bull-case target of $95.95 and a bear-case floor of $49.87.